1025374

Inspection Details

Classification

No Action Indicated (NAI) (NAI)

End Date

September 8, 2017

Fiscal Year

2017

Product Type

Drugs

Project Area

Bioresearch Monitoring

Location

Philadelphia, PA (United States)

Additional Details